TNDM TANDEM DIABETES CARE INC revenue, earnings and financials

For the quarter ended June 30, 2026, TANDEM DIABETES CARE INC reported revenue of $255M (up 5.8% from a year earlier), net income of −$21.2M and diluted EPS of −$0.31; over the last four quarters revenue was $1.04B and net income −$63.3M; for the fiscal year ended December 2025 revenue was $1.01B, up 7.9% on the year before.

TNDM annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $1.01B, gross profit $546M, operating income −$187M, net income −$205M (margin -20.2%), EPS −$3.04
• Fiscal year ended Dec 2024: revenue $940M, gross profit $490M, operating income −$99.1M, net income −$96.0M (margin -10.2%), EPS −$1.47
• Fiscal year ended Dec 2023: revenue $748M, gross profit $368M, operating income −$233M, net income −$223M (margin -29.8%), EPS −$3.43
• Fiscal year ended Dec 2022: revenue $801M, gross profit $413M, operating income −$92.8M, net income −$94.6M (margin -11.8%), EPS −$1.47
• Fiscal year ended Dec 2021: revenue $703M, gross profit $376M, operating income $22.7M, net income $15.6M (margin 2.2%), EPS $0.24

TNDM quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $255M (up 5.8% year over year), net income −$21.2M, EPS −$0.31
• Quarter ended Mar 31, 2026: revenue $247M (up 5.5% year over year), net income −$20.4M, EPS −$0.30
• Quarter ended Dec 31, 2025: revenue $290M (up 2.7% year over year), net income −$589K, EPS −$0.01
• Quarter ended Sep 30, 2025: revenue $249M (up 2.2% year over year), net income −$21.2M, EPS −$0.31
• Quarter ended Jun 30, 2025: revenue $241M (up 8.5% year over year), net income −$52.4M, EPS −$0.78
• Quarter ended Mar 31, 2025: revenue $234M (up 22.3% year over year), net income −$131M, EPS −$1.97
• Quarter ended Dec 31, 2024: revenue $283M (up 43.6% year over year), net income $755K, EPS $0.01
• Quarter ended Sep 30, 2024: revenue $244M (up 31.4% year over year), net income −$23.3M, EPS −$0.35
• Quarter ended Jun 30, 2024: revenue $222M (up 13.3% year over year), net income −$30.8M, EPS −$0.47
• Quarter ended Mar 31, 2024: revenue $192M (up 13.2% year over year), net income −$42.7M, EPS −$0.65
• Quarter ended Dec 31, 2023: revenue $197M (down 10.8% year over year), net income −$30.0M, EPS −$0.46
• Quarter ended Sep 30, 2023: revenue $186M (down 9.3% year over year), net income −$33.0M, EPS −$0.51
• Quarter ended Jun 30, 2023: revenue $196M (down 2.2% year over year), net income −$35.8M, EPS −$0.55
• Quarter ended Mar 31, 2023: revenue $169M (down 3.7% year over year), net income −$124M, EPS −$1.92
• Quarter ended Dec 31, 2022: revenue $221M (up 5.0% year over year), net income −$15.9M, EPS −$0.25
• Quarter ended Sep 30, 2022: revenue $205M (up 13.9% year over year), net income −$49.0M, EPS −$0.76
• Quarter ended Jun 30, 2022: revenue $200M (up 16.3% year over year), net income −$15.1M, EPS −$0.24
• Quarter ended Mar 31, 2022: revenue $176M (up 24.7% year over year), net income −$14.7M, EPS −$0.23
• Quarter ended Dec 31, 2021: revenue $210M, net income $10.8M, EPS $0.16
• Quarter ended Sep 30, 2021: revenue $180M, net income $5.79M, EPS $0.09

TNDM cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$9.72M, share buybacks $0
• Fiscal year ended Dec 2024: operating cash flow $24.2M, share buybacks $30.0M
• Fiscal year ended Dec 2023: operating cash flow −$31.8M, share buybacks $0
• Fiscal year ended Dec 2022: operating cash flow $50.5M, share buybacks $0
• Fiscal year ended Dec 2021: operating cash flow $111M, share buybacks n/a

TNDM balance sheet

• Jun 30, 2026: cash $62.8M, total assets $1.15B, total liabilities $1.02B, shareholders' equity $130M, long-term debt $603M
• Mar 31, 2026: cash $179M, total assets $1.15B, total liabilities $1.02B, shareholders' equity $132M, long-term debt $602M
• Dec 31, 2025: cash $90.6M, total assets $881M, total liabilities $726M, shareholders' equity $155M, long-term debt $310M
• Sep 30, 2025: cash $91.9M, total assets $875M, total liabilities $742M, shareholders' equity $133M, long-term debt $310M
• Jun 30, 2025: cash $64.1M, total assets $876M, total liabilities $742M, shareholders' equity $133M, long-term debt $309M
• Mar 31, 2025: cash $53.6M, total assets $922M, total liabilities $767M, shareholders' equity $155M, long-term debt $309M
• Dec 31, 2024: cash $69.2M, total assets $968M, total liabilities $705M, shareholders' equity $263M, long-term debt $308M
• Sep 30, 2024: cash $49.0M, total assets $958M, total liabilities $720M, shareholders' equity $238M, long-term debt $308M

What is TNDM's revenue?

TANDEM DIABETES CARE INC reported $1.04B of revenue over its last four quarters, through June 30, 2026.

Is TNDM profitable?

No. TANDEM DIABETES CARE INC lost $63.3M over the last four quarters.

What is TNDM's EPS?

Diluted earnings per share over the last four quarters were −$0.93; −$0.31 in the latest quarter.

TNDM ownership and insider trades · All stocks